Literature DB >> 21633027

Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia.

Tesfaye Gelanew1, Zewdu Hurissa, Ermias Diro, Aysheshm Kassahun, Katrin Kuhls, Gabriele Schönian, Asrat Hailu.   

Abstract

We report paired strains of Leishmania parasites, one from the viscera and the other from skin lesions that were isolated from three patients with visceral leishmaniasis and disseminated cutaneous leishmaniasis that were co-infected with human immunodeficiency virus. The causative parasites were characterized by polymerase chain reaction-restriction length polymorphism of the ribosomal DNA internal transcribed spacer 1 and by a panel of multilocus microsatellite markers. We demonstrated that the causative agent was Leishmania donovani in all cases, irrespective of the phenotype of the disease. The paired strains from viscera and skin lesions of the same patients showed genetic identity across the 14 microsatellite markers investigated. These findings demonstrate that the skin lesions in these human immunodeficiency virus-positive patients with visceral leishmaniasis were caused by dissemination of viscerotropic L. donovani parasites as a consequence of severe immunosuppression. However, in all three patients, rapid clearance of the skin lesions was observed after antimonial therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633027      PMCID: PMC3110352          DOI: 10.4269/ajtmh.2011.11-0055

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  47 in total

1.  Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.

Authors:  E Boumis; P Chinello; C Della Rocca; M G Paglia; M F Proietti; N Petrosillo
Journal:  Int J STD AIDS       Date:  2006-05       Impact factor: 1.359

2.  Multilocus microsatellite typing (MLMT) reveals genetically isolated populations between and within the main endemic regions of visceral leishmaniasis.

Authors:  Katrin Kuhls; Lyvia Keilonat; Sebastian Ochsenreither; Matthias Schaar; Carola Schweynoch; Wolfgang Presber; Gabriele Schönian
Journal:  Microbes Infect       Date:  2007-01-09       Impact factor: 2.700

3.  Visceral leishmaniasis in northern Ethiopia.

Authors:  T Haile; S D Anderson
Journal:  East Afr Med J       Date:  2006-07

4.  [Cutaneous leishmaniasis due to Leishmania major involving the bone marrow in an AIDS patient in Burkina Faso].

Authors:  F Barro-Traoré; L Preney; A Traoré; H Darie; P Tapsoba; A Bassolé; S Sawadogo; P Niamba; E Grosshans; M Geniaux
Journal:  Ann Dermatol Venereol       Date:  2008-04-18       Impact factor: 0.777

5.  Visceral leishmaniasis and HIV in Tigray, Ethiopia.

Authors:  Suzi Lyons; Hans Veeken; Jean Long
Journal:  Trop Med Int Health       Date:  2003-08       Impact factor: 2.622

Review 6.  Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.

Authors:  S Antinori; E Longhi; G Bestetti; R Piolini; V Acquaviva; A Foschi; S Trovati; C Parravicini; M Corbellino; L Meroni
Journal:  Br J Dermatol       Date:  2007-09-13       Impact factor: 9.302

7.  Isoenzymatic variability of Leishmania infantum in Tunisia concerning 254 human strains.

Authors:  K Kallel; F Pratlong; N Haouas; E Kaouech; S Belhadj; S Anane; J P Dedet; H Babba; E Chaker
Journal:  Acta Trop       Date:  2008-02-29       Impact factor: 3.112

Review 8.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

9.  Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.

Authors:  Rachel ter Horst; Simon M Collin; Koert Ritmeijer; Adey Bogale; Robert N Davidson
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

Review 10.  Immune reconstitution disease associated with parasitic infections following antiretroviral treatment.

Authors:  S D Lawn; R J Wilkinson
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

View more
  10 in total

1.  Para-kala-azar dermal Leishmaniasis cases in Indian subcontinent - A case series.

Authors:  Rakesh Kumar; Vidya Nand Rabi Das; Roshan Kamal Topno; Biplab Pal; Adnan Imam; Kanhaiya Agrawal; Anima Singh; Krishna Murti; Chandra Shekhar Lal; Neena Verma; Pradeep Das; Krishna Pandey
Journal:  Pathog Glob Health       Date:  2016-11-22       Impact factor: 2.894

2.  Insights into the structural patterns of the antileishmanial activity of bi- and tricyclic N-heterocycles.

Authors:  Lizzi Herrera; David E Stephens; Abigail D'Avila; Kathryn G George; Hadi Arman; Yu Zhang; George Perry; Ricardo Lleonart; Oleg V Larionov; Patricia L Fernández
Journal:  Org Biomol Chem       Date:  2016-07-04       Impact factor: 3.876

Review 3.  PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.

Authors:  Eduard E Zijlstra
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

4.  Evaluation of microcapillary culture method for the isolation of Leishmania aethiopica parasites from patients with cutaneous lesions in Ethiopia.

Authors:  Lensa Aberra; Adugna Abera; Tariku Belay; Amha Kebede; Endalamaw Gadisa; Geremew Tasew
Journal:  Diagn Progn Res       Date:  2019-03-21

Review 5.  Cutaneous Leishmaniasis Due to Leishmania aethiopica.

Authors:  Saskia van Henten; Wim Adriaensen; Helina Fikre; Hannah Akuffo; Ermias Diro; Asrat Hailu; Gert Van der Auwera; Johan van Griensven
Journal:  EClinicalMedicine       Date:  2019-01-08

Review 6.  Visceral Leishmaniasis and HIV coinfection in East Africa.

Authors:  Ermias Diro; Lutgarde Lynen; Koert Ritmeijer; Marleen Boelaert; Asrat Hailu; Johan van Griensven
Journal:  PLoS Negl Trop Dis       Date:  2014-06-26

7.  Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies.

Authors:  K K G D U L Kariyawasam; A Selvapandiyan; H V Y D Siriwardana; A Dube; P Karunanayake; S A S C Senanayake; R Dey; S Gannavaram; H L Nakhasi; N D Karunaweera
Journal:  Parasitology       Date:  2017-11-08       Impact factor: 3.234

8.  Analysis of genetic polymorphisms and tropism in East African Leishmania donovani by Amplified Fragment Length Polymorphism and kDNA minicircle sequencing.

Authors:  Hanan T Jaber; Asrat Hailu; Francine Pratlong; Patrick Lami; Patrick Bastien; Charles L Jaffe
Journal:  Infect Genet Evol       Date:  2018-07-19       Impact factor: 3.342

9.  First Serological Study Revealing High Humoral Response and Evidence for Antigenic Heterogeneity in Leishmania donovani Induced CL in Sri Lanka.

Authors:  Bhagya Deepachandi; Sudath Weerasinghe; Samantha Ranasinghe; Thisira P Andrahennadi; Mahendra N Wickramanayake; Shantha Siri; Nadira Karunaweera; Vishvanath Chandrasekharan; Mitali Chatterjee; Preethi Soysa; Yamuna Siriwardana
Journal:  Biomed Res Int       Date:  2020-09-29       Impact factor: 3.411

10.  Disseminated cutaneous leishmaniasis: ulcerovegetative and ulcero-crusted lesions.

Authors:  Isabela Martins Sgarbi; Flávia da Silva Domingos Santos; Veridiana Elisa Monteiro; Silvia Nunes Szente Fonseca; Fred Bernardes Filho
Journal:  Braz J Infect Dis       Date:  2016-12-21       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.